Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa Baier

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Social Psychiatry and Psychiatric Epidemiology|October 13, 2018
Clinical significance of assertive community treatment among adolescentsGregory Mantzouranis, Vanessa Baier, Laurent Holzer, et al.
Early Intervention in Psychiatry|July 7, 2012
Early tailored assertive community case management for hard-to-engage adolescents suffering from psychiatric disorders: an exploratory pilot studyVanessa Baier, Jérôme Favrod, Pascale Ferrari, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 20, 2026
Comprehensive Pathophysiology Repository for PBPK Modeling in Liver Cirrhosis: Quantifying Continuous Disease Progression and Population VariabilityAnnika R P Schneider, Vanessa Baier, Jan-Frederik Schlender, et al.
NPJ Systems Biology and Applications|March 7, 2018
Integration of genome-scale metabolic networks into whole-body PBPK models shows phenotype-specific cases of drug-induced metabolic perturbationHenrik Cordes, Christoph Thiel, Vanessa Baier, et al.
Psychiatry Research|June 25, 2016
Can the Health of the Nation Outcome Scales for Children and Adolescents predict the necessity of inpatient stay during assertive community treatment?Sébastien Urben, Gregory Mantzouranis, Vanessa Baier, et al.
Archives of Psychiatric Nursing|September 23, 2016
Timing of Clinical Improvement in Assertive Community Treatment for Adolescents: A Pilot Naturalistic Observational StudySébastien Urben, Gregory Mantzouranis, Vanessa Baier, et al.
Drugs in R&D|December 23, 2024
Evaluation of BCRP-Related DDIs Between Methotrexate and Cyclosporin A Using Physiologically Based Pharmacokinetic ModellingStephan Schaller, Ingrid Michon, Vanessa Baier, et al.
Journal of Psychiatric Practice|May 9, 2015
Clinical Utility of the 2 New Scales of the Health of the Nation Outcome Scales for Children and Adolescents (HoNOSCA): A Naturalistic, Prospective Study in a Psychiatric Unit for AdolescentsSébastien Urben, Sandrine Pihet, Caroline Graap, et al.
Antimicrobial Agents and Chemotherapy|August 3, 2016
A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis ChemotherapyHenrik Cordes, Christoph Thiel, Hélène E Aschmann, et al.
NPJ Systems Biology and Applications|August 8, 2018
Using quantitative systems pharmacology to evaluate the drug efficacy of COX-2 and 5-LOX inhibitors in therapeutic situationsChristoph Thiel, Ines Smit, Vanessa Baier, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Social Psychiatry and Psychiatric Epidemiology|October 13, 2018
Clinical significance of assertive community treatment among adolescentsGregory Mantzouranis, Vanessa Baier, Laurent Holzer, et al.
Early Intervention in Psychiatry|July 7, 2012
Early tailored assertive community case management for hard-to-engage adolescents suffering from psychiatric disorders: an exploratory pilot studyVanessa Baier, Jérôme Favrod, Pascale Ferrari, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 20, 2026
Comprehensive Pathophysiology Repository for PBPK Modeling in Liver Cirrhosis: Quantifying Continuous Disease Progression and Population VariabilityAnnika R P Schneider, Vanessa Baier, Jan-Frederik Schlender, et al.
NPJ Systems Biology and Applications|March 7, 2018
Integration of genome-scale metabolic networks into whole-body PBPK models shows phenotype-specific cases of drug-induced metabolic perturbationHenrik Cordes, Christoph Thiel, Vanessa Baier, et al.
Psychiatry Research|June 25, 2016
Can the Health of the Nation Outcome Scales for Children and Adolescents predict the necessity of inpatient stay during assertive community treatment?Sébastien Urben, Gregory Mantzouranis, Vanessa Baier, et al.
Archives of Psychiatric Nursing|September 23, 2016
Timing of Clinical Improvement in Assertive Community Treatment for Adolescents: A Pilot Naturalistic Observational StudySébastien Urben, Gregory Mantzouranis, Vanessa Baier, et al.
Drugs in R&D|December 23, 2024
Evaluation of BCRP-Related DDIs Between Methotrexate and Cyclosporin A Using Physiologically Based Pharmacokinetic ModellingStephan Schaller, Ingrid Michon, Vanessa Baier, et al.
Journal of Psychiatric Practice|May 9, 2015
Clinical Utility of the 2 New Scales of the Health of the Nation Outcome Scales for Children and Adolescents (HoNOSCA): A Naturalistic, Prospective Study in a Psychiatric Unit for AdolescentsSébastien Urben, Sandrine Pihet, Caroline Graap, et al.
Antimicrobial Agents and Chemotherapy|August 3, 2016
A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis ChemotherapyHenrik Cordes, Christoph Thiel, Hélène E Aschmann, et al.
NPJ Systems Biology and Applications|August 8, 2018
Using quantitative systems pharmacology to evaluate the drug efficacy of COX-2 and 5-LOX inhibitors in therapeutic situationsChristoph Thiel, Ines Smit, Vanessa Baier, et al.
Pageof 3